Karolinska Institute (KI)

Karolinska Institutet (KI), founded in 1810, is Sweden’s only university especially focusing on biomedical sciences. In addition, KI annually awards the Nobel Prize in Physiology or Medicine. KI ranks as one of the world’s leading medical universities, which today account for 40 per cent of all medical research in Sweden.

KI has about 4500 employees, some 600 research groups and 370 professors. Some 80 per cent of KI’s income is devoted to research. Research at KI covers the whole medical research area from fundamental molecular biology to public health and care science. KI provides excellent postgraduate training with 2100 registered PhD students from around the world who are active in basic and clinical research. Infection and inflammation is one key research area at the KI.

The Department of Microbiology, Tumor and Cell Biology (MTC) is one of the largest and most research intense departments at KI with staff of more than 450. MTC is in vicinity of the Public Health Agency of Sweden and the European Center of Infectious Disease control (ECDC). A major research area at MTC is Infection Biology.